bioAffinity Technologies
BIAFW
5 hedge funds and large institutions have $105K invested in bioAffinity Technologies in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
0.27% less ownership
Funds ownership: 2.6% → 2.33% (-0.27%)
69% less capital invested
Capital invested by funds: $343K → $105K (-$238K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$9.33K |
| 2 |
OC
Oarsman Capital
Milwaukee,
Wisconsin
|
+$2.06K |
| 3 |
CS
Clear Street
New York
|
+$169 |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$167 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $68.7K | – | – | – |
|
|
CS
2
Clear Street
New York
| $18.5K | +$169 | +200 | +0.4% |
|
|
3
Citadel Advisors
Miami,
Florida
| $17.1K | +$9.33K | +11,065 | +28% |
|
|
OC
4
Oarsman Capital
Milwaukee,
Wisconsin
| $733 | +$2.06K | +2,448 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $199 | +$167 | +198 | +42% |
|
BIAFW Hedge Fund Activity: Q4 2024 in Review
5 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAFW) for Q4 2024, worth a combined $105K — down 69% from $343K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIAFW positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $9.33K.
- 5 institutional investors held bioAffinity Technologies (BIAFW) as of Q4 2024, up from 4 in Q3 2024.
- Funds reported $105K of bioAffinity Technologies stock for Q4 2024, down 69% quarter-over-quarter.
- 1 fund opened new bioAffinity Technologies positions in Q4 2024 and 0 closed out, a net change of +1 holder.
- The largest bioAffinity Technologies buyer in Q4 2024 was Citadel Advisors, an estimated $9.33K added.
Based on aggregated 13F filings for Q4 2024.